The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 12, 2026
Snapshot (as of Oct 12, 2026): Zimmer Biomet Holdings, Inc. (ZBH) pays a $0.96 annual dividend ($0.24 quarterly), yielding 1.08% at $89.14/share. Next ex-dividend date 2026-09-30. 12+ consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.08%
Annual Dividend: $0.96 per share
Payout Ratio: 23.3%
Ex-Dividend Date: 2026-09-30
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 15
Zimmer Biomet Holdings, Inc. dividend currently yields 0.98%, backed by a business that designs and manufactures orthopedic reconstructive products, including implants and related surgical tools sold across the Americas, Europe, and Asia Pacific. ZBH pays $0.96 per share annually, distributed in quarterly installments of $0.24, with the next ex-dividend date set for September 30, 2026. The low yield reflects a company that has prioritized measured, incremental dividend growth over maximizing income payouts. With a beta of 0.471, ZBH stock moves well below the broader market, which suits investors who value price stability alongside modest income.
Zimmer Biomet Holdings, Inc. pays out 23.4% of earnings as dividends, a payout ratio classified as conservative (below 40%). That leaves a wide buffer between earnings and the dividend obligation, supported by demand for orthopedic reconstructive products and surgical implants, categories tied to ongoing patient need rather than discretionary spending. Zimmer Biomet Holdings, Inc. dividend safety looks well-grounded at current payout levels. The main pressure point is growth: the dividend has been flat at $0.96 per share since 2022, which means any sustained earnings decline could narrow that buffer without a formal cut.
Zimmer Biomet Holdings, Inc. dividend history shows a CAGR of 2.5% per year from 2012 to 2025. The per-share dividend grew from $0.6992 to $0.9600 over that period (2026 is a partial year and excluded from the growth calculation). The largest annual increase in the window was 11.1% in 2013. Growth is slow, and the dividend has been flat at $0.96 since 2022, which means the 2.5% CAGR is pulled up by earlier years. For income investors focused on purchasing power, that stagnation over the past three years is the most relevant data point.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | 0.0% | $0.96 (2022) | $0.96 (2025) |
| 5-Year | +0.6% | $0.93 (2020) | $0.96 (2025) |
| 10-Year | +1.2% | $0.85 (2015) | $0.96 (2025) |
ZBH stock fits dividend investors who prioritize earnings coverage and low price volatility over income maximization. The yield is low (below 2%), and at 0.98% it sits exactly in line with its 5-year average, meaning the market has consistently priced ZBH this way. There is no yield expansion on offer here. What investors get instead is a 23.4% payout ratio that leaves the dividend well-covered, and a beta of 0.471 that keeps price swings modest. The trade-off is straightforward: the dividend has not grown since 2022, and the 2.5% long-run CAGR barely keeps pace with inflation. Zimmer Biomet Holdings, Inc. suits investors who want a low-volatility healthcare holding with a covered dividend, not those seeking meaningful income growth.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-30 | $0.2400 |
| 2026-06-25 | $0.2400 |
| 2026-03-31 | $0.2400 |
| 2025-12-30 | $0.2400 |
| 2025-09-30 | $0.2400 |
| 2025-06-26 | $0.2400 |
| 2025-03-31 | $0.2400 |
| 2024-12-30 | $0.2400 |
| 2024-09-30 | $0.2400 |
| 2024-06-26 | $0.2400 |
| Year | Total Dividends |
|---|---|
| 2026 | $0.7200 |
| 2025 | $0.9600 |
| 2024 | $0.9600 |
| 2023 | $0.9600 |
| 2022 | $0.9600 |
Project income from ZBH with the ZBH dividend calculator or track your full portfolio with the dividend tracker.